Prevalence and patterns of the use of complementary therapies among prostate cancer patients: An epidemiological analysis

Journal of Urology

Volumn 161, Issue 5, 1999, Pages 1521-1524

  Nam, Robert K ^a   Fleshner, Neil ^a,b   Rakovitch, Eileen ^a   Klotz, Laurence ^a   Trachtenberg, John ^a   Choo, Richard ^a   Morton, Gerard ^a   Danjoux, Cyril ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Alternative medicine; Prevalence; Prostatic neoplasms

Indexed keywords

ALPHA TOCOPHEROL; PRASTERONE; SELENIUM; VITAMIN D; ZINC;

ARTICLE; DIET SUPPLEMENTATION; GARLIC; HEALTH CARE COST; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; TOMATO;

EID: 0032850112     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68943-4     Document Type: Article

References (20)

1. Heinonen, O. P., Albanes, D., Virtamo, J., Taylor, P. R., Huttunen, J. K., Hartman, A. M., Haapakoski, J., Malila, N., Rautalahti, M., Ripatti, S., Maenpaa, H., Teerenhovi, L., Koss, L., Virolainen, M. and Edwards, B. K.: Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled clinical trial. J. Natl. Cancer Inst., 90: 440, 1998.
2. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group: The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl. J. Med., 330: 1029, 1994.
3. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Jr., Park, H. K., Sanders, B. B., Jr., Smith, C. L., Taylor, J. R. and the Nutritional Prevention of Cancer Study Group: Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. J.A.M.A., 276: 1957, 1996.
4. Fleshner, N., Huryk, R., Heston, W. and Fair, W.: Vitamin E inhibits the high-fat diet promoted growth of human prostate cancer LNCap xenografts in athymic mice. J. Urol., part 2, 159: 13, abstract 50, 1998.
5. Gerber, G. S., Bales, G., Kirsh, E. and Christiano, A. P.: Medicinal botanicals in the treatment of lower urinary tract symptoms (LUTS): a demographic analysis of awareness and use at the University of Chicago., J. Urol., part 2, 159: 334, abstract 1282, 1998.
6. Meydani, M.: Vitamin E. Lancet, 345: 170, 1995.
7. Fair, W. R., Fleshner, N. E. and Heston, W.: Cancer of the prostate: a nutritional disease? Urology, 50: 840, 1997.
8. Giovannucci, E., Rimm, E. B., Colditz, G. A., Stampfer, M. J., Ascherio, A., Chute, C. C., and Willet, W. C.: A prospective study of dietary fat and risk of prostate cancer. J. Natl. Cancer Inst., 85: 1571, 1993.
9. Schwartz, G. G. and Hulka, B. S.: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res., suppl., 10: 1307, 1990.
10. Adlercreutz, H., Markkanen, H., and Watanabe, S.: Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342: 1209, 1993.
11. Giovannucci, E., Ascherio, A., Rimm, E. B., Stampfer, M. J., Colditz, G. A. and Willett, W. C.: Intake of carotenoids and retinol in relation to risk of prostate cancer. J. Natl. Cancer Inst., 87: 1767, 1995.
12. Zaichick, V. Ye., Sviridova, T. V. and Zaichick, S. V.: Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int. Urol. Nephrol., 29: 565, 1997.
13. Massion, A. O., Teas, J., Hebert, J. R., Wertheimer, M. D. and Kabat-Zinn, J.: Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. Med. Hypoth., 44: 39, 1995.
14. Moses, M. A., Sudhalter, J. and Langer, R.: Identification of an inhibitor of neovascularization from cartilage. Science, 248: 1408, 1990.
15. Pinto, J. T., Qiao, C., Xing, J., Rivlin, R. S., Protomastro, M. L., Weissler, M. L., Tao, Y., Thaler, H. and Heston, W. D. W.: Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Amer. J. Clin. Nutr., 66: 398, 1997.
16. Hsieh, T., Chen, S. S., Wang, X. and Wu, J. M.: Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem. Molec. Biol. Int., 42: 535, 1997.
17. Shimada, H., Tyler, V. E. and McLaughlin, J. L.: Biologically active acylglycerides from the berries of saw-palmetto (Serenoa repens). J. Nat. Prod., 60: 417, 1997.
18. Hantson, P., Lievens, M. and Mahieu, P.: Accidental ingestion of a zinc and copper sulfate preparation. J. Toxicol. Clin. Toxicol., 34: 725, 1996.
19. Stumpf, W. E.: Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting. Histochem. Cell Biol., 104: 417, 1995.
20. Holliman, B. J. and Chyka, P. A.: Problems in assessment of acute melatonin overdose. South. Med. J., 90: 451, 1997.